COMPANY
Conrad Biotech Pte Ltd is a Singaporean biopharmaceutical company that offers technologies development including stem cells, immune cells and small molecule antibodies for regenerative medicine and cancer treatments. Our technologies cover a few pre-clinical validation and early-phase assessment of indications such as ischemic stroke, acute myocardial infraction, Parkinson's disease, multiple sclerosis, ostero arthritis, and both liquid and solid cancers. Conrad’s research and core technologies continually ensure public safety and feasibility in patient conditioning. Moreover, Conrad is committed to establish a better technology platform for developing the next generation drugs and treatments for cerebrovascular, cardiovascular diseases, and to seek possible transformation turning fatal cancers to chronic illness for the wellbeing of cancers patients.
NEWS & EVENTS
-
[NEWS] June. 2020.Researchers at UCSD School of Medicine have used induced pluripotent stem cells (iPSCs) and deleting a key gene to create NK cells against leukemia both in vivo and in vitro.DOI:https://doi.org/10.1016/j.stem.2020.05.008 -
[NEWS] April. 2020. Citius Signs exclusive option with Novellus to license Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) associated with COVID-19. -
【EVENT】Mar. 2020. Conrad General Manager and Chief Science Officer visited China Medical University Hospital of Taiwan for the exchange of experience on building cell processing units and the fulfilment of guidelines for inspection. -
【EVENT】Feb. 2020. Conrad noted COVID-19 pandemic and the successful controls on the virus prevention, and decided to boost cooperation with pharma industries in Taiwan.
INFRASTRUCTURE
The cell production site in Singapore Science Park is close to National University of Singapore, which is closer to headquarter office and convenient for technology transfer and industry-academia cooperation/collaboration. We take the advantage of the well-established investing ambience by the Singaporean government plus a self-disciplinary standard within our company, we have confidence in creating the best solution for the diseased therapies.